491 related articles for article (PubMed ID: 11175849)
1. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.
Stacker SA; Caesar C; Baldwin ME; Thornton GE; Williams RA; Prevo R; Jackson DG; Nishikawa S; Kubo H; Achen MG
Nat Med; 2001 Feb; 7(2):186-91. PubMed ID: 11175849
[TBL] [Abstract][Full Text] [Related]
2. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats.
Krishnan J; Kirkin V; Steffen A; Hegen M; Weih D; Tomarev S; Wilting J; Sleeman JP
Cancer Res; 2003 Feb; 63(3):713-22. PubMed ID: 12566318
[TBL] [Abstract][Full Text] [Related]
3. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
4. Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis.
Achen MG; Williams RA; Minekus MP; Thornton GE; Stenvers K; Rogers PA; Lederman F; Roufail S; Stacker SA
J Pathol; 2001 Feb; 193(2):147-54. PubMed ID: 11180159
[TBL] [Abstract][Full Text] [Related]
5. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
Zeng Y; Opeskin K; Goad J; Williams ED
Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
[TBL] [Abstract][Full Text] [Related]
6. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.
Karpanen T; Egeblad M; Karkkainen MJ; Kubo H; Ylä-Herttuala S; Jäättelä M; Alitalo K
Cancer Res; 2001 Mar; 61(5):1786-90. PubMed ID: 11280723
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice.
Yanai Y; Furuhata T; Kimura Y; Yamaguchi K; Yasoshima T; Mitaka T; Mochizuki Y; Hirata K
J Exp Clin Cancer Res; 2001 Sep; 20(3):419-28. PubMed ID: 11718224
[TBL] [Abstract][Full Text] [Related]
9. Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D.
McColl BK; Baldwin ME; Roufail S; Freeman C; Moritz RL; Simpson RJ; Alitalo K; Stacker SA; Achen MG
J Exp Med; 2003 Sep; 198(6):863-8. PubMed ID: 12963694
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
[TBL] [Abstract][Full Text] [Related]
11. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
[TBL] [Abstract][Full Text] [Related]
12. [Mechanisms and role of lymphangiogenesis in cancer metastasis].
Dupuy E; Tobelem G
Bull Cancer; 2003 Jul; 90(7):595-9. PubMed ID: 12957800
[TBL] [Abstract][Full Text] [Related]
13. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
[TBL] [Abstract][Full Text] [Related]
14. VEGF-D in association with VEGFR-3 promotes nodal metastasis in human invasive lobular breast cancer.
van Iterson V; Leidenius M; von Smitten K; Bono P; Heikkilä P
Am J Clin Pathol; 2007 Nov; 128(5):759-66. PubMed ID: 17951197
[TBL] [Abstract][Full Text] [Related]
15. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer.
Zeng Y; Opeskin K; Baldwin ME; Horvath LG; Achen MG; Stacker SA; Sutherland RL; Williams ED
Clin Cancer Res; 2004 Aug; 10(15):5137-44. PubMed ID: 15297417
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth.
Laakkonen P; Waltari M; Holopainen T; Takahashi T; Pytowski B; Steiner P; Hicklin D; Persaud K; Tonra JR; Witte L; Alitalo K
Cancer Res; 2007 Jan; 67(2):593-9. PubMed ID: 17234768
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma.
White JD; Hewett PW; Kosuge D; McCulloch T; Enholm BC; Carmichael J; Murray JC
Cancer Res; 2002 Mar; 62(6):1669-75. PubMed ID: 11912138
[TBL] [Abstract][Full Text] [Related]
18. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
Issa A; Le TX; Shoushtari AN; Shields JD; Swartz MA
Cancer Res; 2009 Jan; 69(1):349-57. PubMed ID: 19118020
[TBL] [Abstract][Full Text] [Related]
20. The role of tumor lymphangiogenesis in metastatic spread.
Stacker SA; Baldwin ME; Achen MG
FASEB J; 2002 Jul; 16(9):922-34. PubMed ID: 12087053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
